MedTrace Logo

The Sakakibara Health Integrative Profile Cohort Study

NCT03005834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32095

Last updated 2016-12-30

No results posted yet for this study

Summary

Because of the genetic and traditional commonalities between the underlying causes of atherosclerotic cardiovascular diseases (CVD) and cancers, we hypothesized that patients with atherosclerotic CVD may have a high incidence of cancers when compared with those with non-atherosclerotic CVD. To address this hypothesis, we investigated longitudinal clinical outcomes in a total of 32,095 consecutive patients with CVD enrolled in the Sakakibara Health Integrative Profile (SHIP) cohort study which was launched in 2006 for the purpose of improving healthy life expectancy in patients with CVD in our institute.

Conditions

Interventions

OTHER

incidence of cancers

With a continuous surveillance system to track all subsequent incidents of CVD and/or non-CVD via direct contact in the outpatient department, hospital records, and a mailed questionnaire at least once a year, an incidence of cancers was identified.

Sponsors & Collaborators

  • Sakakibara Heart Institute

    lead OTHER

Principal Investigators

  • Makoto Suzuki, MD · Sakakibara Heart Institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2014-07-31
Completion
2014-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03005834 on ClinicalTrials.gov